351 results on '"Ketter, Ralf"'
Search Results
2. Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status
3. Intracranial Intracerebral Schwannoma: a Case Report and Review of the Literature
4. Schädel-Hirn-Trauma und Kiefer- und Gesichtstrauma
5. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
6. Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas
7. N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.
8. Comparison of the maximum possible lengths of insertable screws in the Subaxial Cervical Spine
9. DNA methylation-based classification of central nervous system tumours.
10. Radiological analyses of the dimensions of the pedicle and dorsal part of the transverse process of subaxial vertebrae in the context of cervical spine surgery
11. The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme
12. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
13. miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme
14. Incidence, mortality and outcome of meningiomas: A population-based study from Germany
15. The intra-tumoral heterogeneity in glioblastoma — a limitation for prognostic value of epigenetic markers?
16. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
17. Fluorescence imaging of meningioma cells with somatostatin receptor ligands: an in vitro study
18. Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p
19. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
20. MicroRNA 200a as a histologically independent marker for meningioma recurrence : Results of a four microRNA panel analysis in meningiomas
21. Supplementary Figure Legends from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
22. Supplementary Tables 1-2 from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
23. Supplementary Figure 1 from MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
24. Supplementary Tables 1-7 from MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
25. Supplementary Figures 1-5 from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
26. Data from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
27. Prognosis of meningiomas in the early 1970s and today
28. Tumor antigen–specific T cells for immune monitoring of dendritic cell–treated glioblastoma patients
29. Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas
30. MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas
31. Schädel-Hirn-Trauma und Kiefer- und Gesichtstrauma
32. Recurrence and Progression in Meningiomas
33. Glioblastoma Patients: p15 Methylation as a Prognostic Factor
34. Schädel-Hirn-Trauma und Kiefer- und Gesichtstrauma
35. Surviving a Self-inflicted Transorbital Pen Intrusion to the Cerebellum: Case Report.
36. TERT Promoter Mutations and Risk of Recurrence in Meningioma
37. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
38. MiRNA-181d Expression Correlates in Tumor versus Plasma of Glioblastoma Patients—the Base of a Preoperative Stratification Tool for Local Carmustine Wafer Use
39. Surviving a Self-inflicted Transorbital Pen Intrusion to the Cerebellum: Case Report
40. PATH-39. INTEGRATED MOLECULAR-MORPHOLOGICAL MENINGIOMA CLASSIFICATION: A MULTICENTER RETROSPECTIVE ANALYSIS, RETRO- AND PROSPECTIVELY VALIDATED
41. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry
42. Review for "Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma"
43. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
44. Red blood cell transfusion in neurosurgery
45. Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma
46. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
47. Impact of MiRNA-181a2 on the Clinical Course of IDH1 Wild Type Glioblastoma
48. Head Injury without Head Blow? A Rare Case of Subdural Hematoma Associated with Minute Arachnoid Cyst in a Teenage Skater
49. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-α-methyl-tyrosine for SPECT imaging of gliomas
50. Ultrasonic Radio-Frequency Spectrum Analysis Differentiates Normal and Edematous Brain Tissue from Meningioma Intraoperatively
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.